DUPIXENT MYWAY Trademark

Trademark Overview

On Wednesday, October 19, 2016, a trademark application was filed for DUPIXENT MYWAY with the United States Patent and Trademark Office. The USPTO has given the DUPIXENT MYWAY trademark a serial number of 87208922. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, December 20, 2023. This trademark is owned by Sanofi Biotechnology. The DUPIXENT MYWAY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information and medical treatment support programs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
dupixent myway

General Information

Serial Number87208922
Word MarkDUPIXENT MYWAY
Filing DateWednesday, October 19, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, December 20, 2023
Registration Number5308193
Registration DateTuesday, October 10, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Description of MarkThe mark consists of the stylized word "DUPIXENT" above the stylized word "MYWAY." Next to these words is a single chevron pointing right.
Pseudo MarkDUPIXENT MY WAY
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding medical information and medical treatment support programs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 26, 2016
Primary Code044
First Use Anywhere DateMonday, April 3, 2017
First Use In Commerce DateMonday, April 3, 2017

Trademark Owner History

Party NameSanofi Biotechnology
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGentilly 94250
FR
Party NameSanofi Biotechnology
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi Biotechnology
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Wednesday, December 20, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, December 20, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, December 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 28, 2023TEAS SECTION 8 RECEIVED
Monday, October 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 6, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 5, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 24, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 26, 2017USE AMENDMENT FILED
Friday, August 18, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 26, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 9, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 9, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 9, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, February 9, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, January 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 28, 2017NON-FINAL ACTION E-MAILED
Saturday, January 28, 2017NON-FINAL ACTION WRITTEN
Friday, January 27, 2017ASSIGNED TO EXAMINER
Thursday, October 27, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, October 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 22, 2016NEW APPLICATION ENTERED

Related Keywords

myway dupixent providing information medical prophylactic therapeutic pharmaceuticals diagnostic properties namely treatment